Activation of the Raf/MAP kinase cascade by the Ras‐related protein TC21 is required for the TC21‐mediated transformation of NIH 3T3 cells

TC21 is a member of the Ras superfamily of small GTP‐binding proteins and, like Ras, has been implicated in the regulation of growth‐stimulating pathways. Point mutations introduced into TC21 based on equivalent H‐Ras oncogenic mutations are transforming in cultured cells, and oncogenic mutations in TC21 have been isolated from several human tumours. The mechanism of TC21 signalling in transformation is poorly understood. While activation of the serine/threonine kinases Raf‐1 and B‐Raf has been implicated in signalling pathways leading to transformation by H‐Ras, it has been argued that TC21 does not activate Raf‐1 or B‐Raf. Since the Raf‐signalling pathway is important in transformation by other Ras proteins, we assessed whether the Raf pathway is important to transformation by TC21. Raf‐1 and B‐Raf are constitutively active in TC21‐transformed cells and the ERK/MAPK cascade is required for the maintenance of the transformed state. We demonstrate that oncogenic V23 TC21, like Ras, interacts with Raf‐1 and B‐Raf (but not with A‐Raf), resulting in the translocation of the Raf proteins to the plasma membrane and in their activation. Furthermore, using point mutations in the effector loop of TC21, we show that the interaction of TC21 with Raf‐1 is crucial for transformation.

[1]  K. Barker,et al.  Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo. , 1998, British Journal of Cancer.

[2]  F. Hobbs,et al.  Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.

[3]  R. Wolthuis,et al.  Ras-dependent activation of the small GTPase Ral , 1998, Current Biology.

[4]  A. Wittinghofer,et al.  Discrimination of Amino Acids Mediating Ras Binding from Noninteracting Residues Affecting Raf Activation by Double Mutant Analysis* , 1997, The Journal of Biological Chemistry.

[5]  J. Bos.  Ras-like GTPases. , 1997, Biochimica et biophysica acta.

[6]  H. Augustin,et al.  Transcriptional regulation of the Ras‐related protein TC21/R‐Ras2 in endothelial cells , 1997, FEBS letters.

[7]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[8]  A Sewing,et al.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[9]  P. Warne,et al.  Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.

[10]  C. Marshall,et al.  Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.

[11]  C. Marshall,et al.  Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases* , 1997, The Journal of Biological Chemistry.

[12]  Jonathan A. Cooper,et al.  TC21 causes transformation by Raf-independent signaling pathways , 1996, Molecular and cellular biology.

[13]  M. Wigler,et al.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation , 1996, Molecular and cellular biology.

[14]  P. Dent,et al.  Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation , 1996, Molecular and cellular biology.

[15]  M. Barbacid,et al.  The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor. , 1996, Oncogene.

[16]  C. Der,et al.  Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. , 1996, Oncogene.

[17]  S. Aaronson,et al.  A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. , 1995, Oncogene.

[18]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Marshall,et al.  Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. , 1995, The EMBO journal.

[20]  A. Wittinghofer,et al.  The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with RaplA and a GTP analogue , 1995, Nature.

[21]  M. Wigler,et al.  Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.

[22]  S. Aaronson,et al.  A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Jonathan A. Cooper,et al.  A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Marshall,et al.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.

[25]  P. D’Eustachio,et al.  Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation , 1994, Molecular and cellular biology.

[26]  A. Ashworth,et al.  Identification of the sites in MAP kinase kinase‐1 phosphorylated by p74raf‐1. , 1994, The EMBO journal.

[27]  P. Cohen,et al.  Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells. , 1993, Oncogene.

[28]  M. Wigler,et al.  Complex formation between RAS and RAF and other protein kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Weinberg,et al.  Characterization of a guanine nucleotide dissociation stimulator for a ras‐related GTPase. , 1993, The EMBO journal.

[30]  P. Cohen,et al.  Activation of the MAP kinase pathway by the protein kinase raf , 1992, Cell.

[31]  Philip R. Cohen,et al.  MAP kinase activator from insulin‐stimulated skeletal muscle is a protein threonine/tyrosine kinase. , 1992, The EMBO journal.

[32]  T. Roberts,et al.  Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Leevers,et al.  Activation of extracellular signal‐regulated kinase, ERK2, by p21ras oncoprotein. , 1992, The EMBO journal.

[34]  J. Shabanowitz,et al.  Identification of the regulatory phosphorylation sites in pp42/mitogen‐activated protein kinase (MAP kinase). , 1991, The EMBO journal.

[35]  E. Krebs,et al.  Multiple components in an epidermal growth factor-stimulated protein kinase cascade. In vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. , 1991, The Journal of biological chemistry.

[36]  P. D’Eustachio,et al.  Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line , 1990, Molecular and cellular biology.

[37]  G K Lewis,et al.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product , 1985, Molecular and cellular biology.

[38]  M. Wigler,et al.  Ras partners. , 1994, Cold Spring Harbor symposia on quantitative biology.

[39]  J. R. Johnston.  Molecular genetics of yeast :a practical approach , 1994 .

[40]  N. Williams.  Both p21^ and pp60^ are required, but neither is sufficient, to activate the Raf-1 kinase. , 1992 .

[41]  M. Barbacid.  ras genes. , 1987, Annual review of biochemistry.